Follow The Filings

LLY Eli Lilly

Eli Lilly earnings company data as of 7:06 PM ET 10/30

  • 1 of 2 EPS beats
  • 3 Owners
  • Rank #51
  • Max 0.6%
  • Master 0.11%

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS 9.56 7.48 Miss -21.8%
Rev $22.62B $24.40B Beat +7.9%
FY2026 Q2 5 Aug EPS 6.01 7.94 Beat +32.1%
Rev — — —

Who owns this now

Largest portfolio weights among holders, up to 0.6% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

All holders
  1. Kentucky Trust Co. Add 0.60%
  2. Torray Investment Partners 0.06%
  3. David Katz Reduce 0.03%

Insider trades

Open-market buys and sales by LLY's executives, directors and 10% owners in the last 12 months, from their Form 4s

All LLY insider trades
  • None no insider bought on the open market
  • $78.4B sold by 1 insider outside a trading plan
  • $19.8M sold by 4 insiders under 10b5-1 plans
  1. Patrik Jonsson EVP & President, LLY Int'l
    Planned sale
    $7.6M 6,500 shares at $1,175.10 11% of stake
    Traded Aug 17 Filed Aug 18
  2. Donald A Zakrowski SVP, Finance, & CAO
    Planned sale
    $2.4M 2,000 shares at $1,185.01 57% of stake
    Traded Aug 10 Filed Aug 11
  3. Anat Hakim EVP, GC & Secretary
    Planned sale
    $6M 5,000 shares at $1,190.00 30% of stake
    Traded Aug 7 Filed Aug 10
  4. Ilya Yuffa EVP&Pres, LLY USA&Global Capab
    Planned sale
    $2.9M 2,500 shares at $1,150.77 7.7% of stake
    Traded Jun 10 Filed Jun 11
  5. Lilly Endowment Inc. Insider
    Sale
    $15.8M 15,828 shares at $995.36 <0.1% of stake
    Traded May 6 Filed May 7
  6. Lilly Endowment Inc. 10% owner
    Sale
    $322M 292,148 shares at $1,103.48 0.3% of stake
    Traded Jan 7 Filed Jan 8
  7. Lilly Endowment Inc. 10% owner
    Sale
    $1.5M 1,390 shares at $1,085.01 <0.1% of stake
    Traded Jan 5 Filed Jan 6
  8. Lilly Endowment Inc. 10% owner
    Sale
    $3.9M 3,593 shares at $1,085.04 <0.1% of stake
    Traded Dec 29, 2025 Filed Dec 30, 2025
  9. Lilly Endowment Inc. 10% owner
    Sale
    $2.9M 2,629 shares at $1,085.17 <0.1% of stake
    Traded Dec 24, 2025 Filed Dec 29, 2025
  10. Lilly Endowment Inc. 10% owner
    Sale
    $260K 240 shares at $1,085.04 <0.1% of stake
    Traded Dec 23, 2025 Filed Dec 29, 2025
  11. Lilly Endowment Inc. 10% owner
    Sale
    $17.3M 15,632 shares at $1,109.30 <0.1% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
  12. Lilly Endowment Inc. 10% owner
    Sale
    $161M 147,061 shares at $1,095.35 0.2% of stake
    Traded Nov 25, 2025 Filed Nov 26, 2025
  13. Lilly Endowment Inc. 10% owner
    Sale
    $152M 142,307 shares at $1,068.52 0.2% of stake
    Traded Nov 24, 2025 Filed Nov 25, 2025
  14. Lilly Endowment Inc. 10% owner
    Sale
    $112M 105,326 shares at $1,058.66 0.1% of stake
    Traded Nov 21, 2025 Filed Nov 24, 2025
  15. Lilly Endowment Inc. 10% owner
    Sale
    $39.1M 37,148 shares at $1,051.66 <0.1% of stake
    Traded Nov 20, 2025 Filed Nov 21, 2025

Also filed in the last 12 months, not counted as buying or selling: 56 stock grants, 5 gifts, 1 option exercise, and 1 share withholding for taxes.

SEC filings

Recent issuer filings from EDGAR, 11 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13D —
10-Q
8-K 2.02,9.01
SCHEDULE 13D —
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 8.01,9.01

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.